Beyer, S.; Zhu, J.; Mayr, D.; Kuhn, C.; Schulze, S.; Hofmann, S.; Dannecker, C.; Jeschke, U.; Kost, B.P.
Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer. Int. J. Mol. Sci. 2017, 18, 477.
https://doi.org/10.3390/ijms18030477
AMA Style
Beyer S, Zhu J, Mayr D, Kuhn C, Schulze S, Hofmann S, Dannecker C, Jeschke U, Kost BP.
Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer. International Journal of Molecular Sciences. 2017; 18(3):477.
https://doi.org/10.3390/ijms18030477
Chicago/Turabian Style
Beyer, Susanne, Junyan Zhu, Doris Mayr, Christina Kuhn, Sandra Schulze, Simone Hofmann, Christian Dannecker, Udo Jeschke, and Bernd P. Kost.
2017. "Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer" International Journal of Molecular Sciences 18, no. 3: 477.
https://doi.org/10.3390/ijms18030477
APA Style
Beyer, S., Zhu, J., Mayr, D., Kuhn, C., Schulze, S., Hofmann, S., Dannecker, C., Jeschke, U., & Kost, B. P.
(2017). Histone H3 Acetyl K9 and Histone H3 Tri Methyl K4 as Prognostic Markers for Patients with Cervical Cancer. International Journal of Molecular Sciences, 18(3), 477.
https://doi.org/10.3390/ijms18030477